
GHRS
Healthcare · Biotechnology · $1.31B market cap
$19.10+0.61 (+3.3%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -2.1% over 90 days · 30-day revisions 6 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Time not confirmed | -0.30 | -0.18 | +40.4% |
| Aug 6, 2026 | Before the open | -0.31 | -0.23 | +25.8% |
| May 14, 2026 | Before the open | -0.26 | -0.31 | -19.2% |
| Feb 26, 2026 | Time not confirmed | -0.27 | -0.22 | +17.8% |
| Nov 6, 2025 | Before the open | -0.23 | -0.23 | 0.0% |
| Aug 7, 2025 | Before the open | -0.22 | -0.15 | +31.8% |
| May 8, 2025 | Before the open | -0.20 | -0.19 | +5.0% |
| Feb 27, 2025 | Time not confirmed | -0.22 | -0.17 | +23.3% |
| Nov 14, 2024 | Before the open | -0.25 | -0.23 | +8.0% |
| Sep 3, 2024 | Time not confirmed | -0.22 | -0.20 | +9.1% |
| May 3, 2024 | Before the open | -0.22 | -0.15 | +31.8% |
| Feb 29, 2024 | Before the open | -0.20 | -0.21 | -5.0% |
| Nov 9, 2023 | After the close | -0.20 |
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and…
| -0.11 |
| +45.0% |
| Aug 23, 2023 | Before the open | -0.21 | -0.15 | +28.6% |
| May 11, 2023 | Before the open | -0.19 | -0.21 | -10.5% |
| Mar 2, 2023 | Before the open | -0.17 | -0.32 | -88.2% |
| Nov 10, 2022 | Before the open | -0.16 | -0.01 | +93.8% |
| Aug 23, 2022 | Before the open | -0.17 | 0.01 | +105.9% |
| May 18, 2022 | Before the open | -0.16 | -0.11 | +31.3% |
| Mar 28, 2022 | Before the open | -0.17 | -0.09 | +47.1% |
| Dec 6, 2021 | Before the open | -0.17 | -0.04 | +76.5% |
| Sep 23, 2021 | After the close | -0.08 | -0.05 | +37.5% |
| Jun 28, 2021 | After the close | 0.00 | -0.01 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.02 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |